Compounds > bucindolol
Page last updated: 2024-08-23

bucindolol and isoproterenol

bucindolol has been researched along with isoproterenol in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19904 (66.67)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Curzio, J; Reid, JL; Vincent, J1
Marwood, JF; Stokes, GS1
Oates, HF; Stoker, LM; Stokes, GS1
Aarhus, LL; Lorenz, RR; Rimele, TJ; Rooke, TW; Vanhoutte, PM1
Bölck, B; Brixius, K; Bundkirchen, A; Mehlhorn, U; Schwinger, RH1
Baker, JG; Fretwell, L; Gardiner, SM; Hill, SJ; Kemp, P; March, J1

Other Studies

6 other study(ies) available for bucindolol and isoproterenol

ArticleYear
Bucindolol in essential hypertension.
    International journal of clinical pharmacology research, 1985, Volume: 5, Issue:5

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Creatine Kinase; Drug Administration Schedule; Heart Rate; Humans; Hypertension; Isoproterenol; Middle Aged; Norepinephrine; Phenylephrine; Posture; Propanolamines; Receptors, Adrenergic, alpha; Renin

1985
Studies on the vasodilator actions of bucindolol in the rat.
    Clinical and experimental pharmacology & physiology, 1986, Volume: 13, Issue:1

    Topics: Animals; Blood Pressure; Dose-Response Relationship, Drug; Heart Rate; Isoproterenol; Prazosin; Propanolamines; Propranolol; Rats; Rats, Inbred Strains; Vagotomy; Vasodilation

1986
Studies in the rat on bucindolol, a new antihypertensive agent with beta-adrenoceptor blocking properties.
    Archives internationales de pharmacodynamie et de therapie, 1981, Volume: 251, Issue:1

    Topics: Adrenergic beta-Antagonists; Angiotensin II; Animals; Antihypertensive Agents; Dose-Response Relationship, Drug; Epinephrine; Hemodynamics; Indoles; Isoproterenol; Norepinephrine; Propanolamines; Rats; Time Factors

1981
Pharmacology of bucindolol in isolated canine vascular smooth muscle.
    The Journal of pharmacology and experimental therapeutics, 1984, Volume: 231, Issue:2

    Topics: Adrenergic beta-Antagonists; Animals; Azepines; Dogs; Dose-Response Relationship, Drug; Electric Stimulation; Female; In Vitro Techniques; Isoproterenol; Male; Muscle, Smooth, Vascular; Norepinephrine; Propanolamines; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta

1984
Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium.
    British journal of pharmacology, 2001, Volume: 133, Issue:8

    Topics: Adrenergic beta-Antagonists; Benzopyrans; Binding, Competitive; Bisoprolol; Carbazoles; Carvedilol; Ethanolamines; Female; Guanylyl Imidodiphosphate; Heart Ventricles; Humans; Imidazoles; In Vitro Techniques; Inhibitory Concentration 50; Isoproterenol; Male; Metoprolol; Middle Aged; Myocardial Contraction; Myocardium; Nebivolol; Propanolamines; Substrate Specificity; Sympathetic Nervous System; Sympathomimetics; Thermodynamics

2001
Predicting in vivo cardiovascular properties of β-blockers from cellular assays: a quantitative comparison of cellular and cardiovascular pharmacological responses.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2011, Volume: 25, Issue:12

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cardiovascular Agents; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Heart Rate; Humans; Imidazoles; Isoproterenol; Male; Phenoxyacetates; Phenoxypropanolamines; Propanolamines; Rats; Rats, Sprague-Dawley; Vascular Resistance; Xamoterol

2011